A detailed history of Lazard Asset Management LLC transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 1,394 shares of SGHT stock, worth $5,548. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,394
Previous 9,121 84.72%
Holding current value
$5,548
Previous $60,000 86.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.49 - $8.31 $42,421 - $64,211
-7,727 Reduced 84.72%
1,394 $8,000
Q2 2024

Aug 14, 2024

SELL
$5.13 - $7.15 $35 - $50
-7 Reduced 0.08%
9,121 $60,000
Q1 2024

May 14, 2024

SELL
$4.02 - $5.89 $2,629 - $3,852
-654 Reduced 6.69%
9,128 $48,000
Q4 2023

Feb 14, 2024

BUY
$1.29 - $5.86 $12,618 - $57,322
9,782 New
9,782 $50,000
Q4 2022

Feb 14, 2023

BUY
$5.58 - $13.94 $25,104 - $62,716
4,499 New
4,499 $54,000

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $190M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.